Decrease in spontaneous motor activity and in brain lipid peroxidation in manganese and melatonin treated mice

Neurochemical Research

Volumn 24, Issue 5, 1999, Pages 705-708

  Talavera, Enrique José ^a   Arcaya, José Luis ^a   Giraldoth, Débora ^a   Suárez, Jacqueline ^a   Bonilla, Ernesto ^a,b  

^a Instituto de Investigaciones Biomedicas   (Venezuela)

^b UNIVERSIDAD DEL ZULIA   (Venezuela)

Author keywords

Malondialdehyde formation; Manganese; Melatonin; Motor activity

Indexed keywords

MALONALDEHYDE; MANGANESE; MELATONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DOPAMINE RELEASE; EXTRAPYRAMIDAL SYMPTOM; LIPID METABOLISM; LIPID PEROXIDATION; LOCOMOTION; MOTOR ACTIVITY; MOUSE; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SEROTONIN RELEASE;

ANIMALS; BRAIN; DRUG INTERACTIONS; KINETICS; LIPID PEROXIDATION; MALONDIALDEHYDE; MANGANESE; MELATONIN; MICE; MOTOR ACTIVITY;

ANIMALIA;

EID: 0032914658     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021064711866     Document Type: Article

References (22)

1. Paynter, D. I. 1980. The role of dietary copper, manganese, selenium, and vitamin E in lipid peroxidation in tissues of the rat, Biol. Trace Elem. Res. 2:121-135.
2. Sziraki, I., Mohanakumar, K. P., Rauhala, P., Kim, H. G., Yeh, K. J., and Chiueh, C. C. 1998. Manganese a transition metal protects negrostriatal neurons from oxidative stress in the iron-induced animal model of parkinsonism. Neuroscience. 85(4):1101-1111.
3. Rojas, P., and Rios, C. 1995. Short term manganese pretreatment partially protects against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. Neurochem. Res. 20(10):1217-1223.
4. Donaldson, J. 1987. The physiopathologic significance of manganese in brain: Its relation to schizophrenia and neurodegenerative disorders, Neurotoxicology., 8:451-462.
5. Graham, D. J., 1984. Catecholamine toxicity. A proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease., Neurotoxicology., 5:83-96.
6. Komura, J., and Sakamoto, M. 1991. Short-term oral administration of several manganese compounds in mice: Physiological and behavioral alterations caused by different forms of manganese, Bull. Environ. Contam. Toxicol. 46:921-928.
7. Komura, J. and Sakamoto, M. 1992. Effects of manganese form on biogenic amines in the brain and behavioral alterations in the mouse: Long-term oral administration of several manganese compounds, Environ. Res. 57:34-44.
8. Cano, G., Suarez-Roca, H., Gomez, G., Arcaya, J. L., Aversano, C., Latan, J. C. and Bonilla, E. 1996. Metal Ions in Biology and Medicine, vol 4, Collery, Ph., Corbella, J., Domingo, J. L., Etienne, J. C. and Llobet, J. M. (Eds), John Libbery Eurotext, Paris, pp. 472-474.
9. Melchiorri, D., Reiter, R. J., Sewerynek, E., Chen, L. D. and Nisticó, G. 1995. Melatonin reduces kainate-induced lipid peroxidation in homogenates of different brain regions, FASEB J., 9:1205-1210.
10. Chuang, J. I., Lim, M. T., 1994. Pharmacological effects of melatonin treatment on both locomotor activity and brain serotonin release in rats, J. Pineal Res., 17,1:11-16
11. Golombek D. A., Escolar, E., and Cardinali, D. P., 1991. Melatonin-induced depression of locomotor activity in hamsters: time-dependency and inhibition by central-type benzodiazepine antagonist Ro 15-1788, Physiol. Behav., 49(6):1091-7.
12. Ohkawa, H., Ohishi, N. and Yagi, K. 1979. Assay for lipid peroxides in animal tissues by Thiobarbituric acid reaction, Anal. Biochem., 95:351-358.
13. Coassin, M., Ursini, F. and Bindoli, A. 1992 Antioxidant effect of manganese, Arch. Biochem. Biophisys., 299:330-333.
14. Tampo, Y. and Yonaha, M.. 1992. Antioxidant mechanism of Mn (II) in phospholipid peroxidation, Free Rad. Biol. Med., 13:115-120.
15. Donaldson, J., Mc Gregor, D. and La Bella, F.S. 1982. Manganese neurotoxicity: A model for free radical mediated neurodegeneration, Can. J. Physiol. Pharmacol., 60:1398-1405.
16. Shukla. G. S. and Chandra, S. V. 1981. Manganese toxicity: Lipid peroxidation in rat brain, Acta Pharmacol. Toxicol., 48:95-100.
17. Sziráki, I., Rauhala, P., and Chiueh, C. C. 1995. Novel protective effect of manganese against ferrous citrate-induced lipid peroxidation and nigrostriatal neurodegeneration in vivo. Brain Res., 698:285-287.
18. Kotler, M., Rodriguez, C., Sainz, R. M., Antolin, I., Menendez-Pelaez, A. 1998. Melatonin increases gene expression for antioxidant enzymes in rat brain cortex. J. Pineal Res. 24 (2):83-89.
19. Antolin, I., Rodriguez, C., Sains, R. M., Mayo, J. C., Uria, H., Kotler M. L., Rodriguez-Colunga, M. J., Tolivia, D., Menendez-Pelaez, A. 1996. Neurohormone melatonin prevent cell damage: effect on gene expression for antioxidant enzymes, FASEB J., 10 (8):882-890.
20. Barlow - Walden, L. R., Reiter, R. J., Abe, M., Pablos, M., Menéndez-Pelaez A., Chen, L. D. and Poeggeler, B. 1995. Melatonin stimulates brain glutathione peroxidase activity, Neurochem. Int., 26:497-502.
21. Cotzias, G. C., Papavasiliou, P. S., Mena, I., Tang, L. C., Miller, S. T. 1974. Manganese and catecholamines. Adv. Neurol. 5:235-243.
22. Kumar, R., Srivastava, S., Agrawal, K. and Seth, P. K., 1996. Alteration in. some membrane properties in rat brain following exposure to manganese, Pharmacol. Toxicol., 79:47-48.